Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn Iganej

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 26, 2011
In regard to Gopal et al. ACR appropriateness criteria on induction and adjuvant therapy for stage N2 non-small-cell lung cancer: expert panel on radiation oncology-lung (Int J Radiat Oncol Biol Phys 2010;78:969-974)Joseph Hastings, Shawn Iganej
American Journal of Clinical Oncology|August 8, 2006
The case for case reports: avoiding statistical seductionA Robert Kagan, Raoul J Burchette, Shawn Iganej
Head & Neck|May 31, 2013
Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapyMargaret S Soper, Shawn Iganej, Lester D R Thompson
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapyAfshin Rashtian, Shawn Iganej, In-Lu Amy Liu, et al.
Head and Neck Pathology|November 20, 2019
Oropharyngeal Squamous Cell Carcinoma in 390 Patients: Analysis of Clinical and Histological Criteria Which Significantly Impact OutcomeLester D R Thompson, Raoul Burchette, Shawn Iganej, et al.
American Journal of Clinical Oncology|February 23, 2013
Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancerJoseph Hastings, Shawn Iganej, Cynthia Huang, et al.
Head & Neck|December 16, 2018
Radiographic nodal prognostic factors in stage I HPV-related oropharyngeal squamous cell carcinomaOnita Bhattasali, Lester D R Thompson, Andrew J Schumacher, et al.
American Journal of Clinical Oncology|September 17, 2016
Concurrent Radiotherapy and Triweekly Carboplatin for the Definitive Treatment of Locally Advanced Laryngeal CarcinomaSharon M Lu, Shawn Iganej, Iman A Abdalla, et al.
Oral Oncology|March 3, 2018
Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 diseaseOnita Bhattasali, Jeannie Han, Lester D R Thompson, et al.
Oral Oncology|July 27, 2019
Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiationOnita Bhattasali, Joan J Ryoo, Lester D R Thompson, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Oncology, Biology, Physics|November 26, 2011
In regard to Gopal et al. ACR appropriateness criteria on induction and adjuvant therapy for stage N2 non-small-cell lung cancer: expert panel on radiation oncology-lung (Int J Radiat Oncol Biol Phys 2010;78:969-974)Joseph Hastings, Shawn Iganej
American Journal of Clinical Oncology|August 8, 2006
The case for case reports: avoiding statistical seductionA Robert Kagan, Raoul J Burchette, Shawn Iganej
Head & Neck|May 31, 2013
Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapyMargaret S Soper, Shawn Iganej, Lester D R Thompson
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapyAfshin Rashtian, Shawn Iganej, In-Lu Amy Liu, et al.
Head and Neck Pathology|November 20, 2019
Oropharyngeal Squamous Cell Carcinoma in 390 Patients: Analysis of Clinical and Histological Criteria Which Significantly Impact OutcomeLester D R Thompson, Raoul Burchette, Shawn Iganej, et al.
American Journal of Clinical Oncology|February 23, 2013
Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancerJoseph Hastings, Shawn Iganej, Cynthia Huang, et al.
Head & Neck|December 16, 2018
Radiographic nodal prognostic factors in stage I HPV-related oropharyngeal squamous cell carcinomaOnita Bhattasali, Lester D R Thompson, Andrew J Schumacher, et al.
American Journal of Clinical Oncology|September 17, 2016
Concurrent Radiotherapy and Triweekly Carboplatin for the Definitive Treatment of Locally Advanced Laryngeal CarcinomaSharon M Lu, Shawn Iganej, Iman A Abdalla, et al.
Oral Oncology|March 3, 2018
Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 diseaseOnita Bhattasali, Jeannie Han, Lester D R Thompson, et al.
Oral Oncology|July 27, 2019
Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiationOnita Bhattasali, Joan J Ryoo, Lester D R Thompson, et al.
Pageof 2